Goldman Sachs
JUNO

Goldman Sachs’s Juno Therapeutics, Inc. JUNO Stock Holding History

Goldman Sachs’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-8,100
Closed -$370K – 6662
2017
Q4 		$370K Sell
8,100
-40,200
-83% -$2.01M ﹤0.01% 5044
2017
Q3 		$2.17M Sell
48,300
-1,300
-3% -$44.3K ﹤0.01% 3916
2017
Q2 		$1.48M Buy
49,600
+26,500
+115% +$654K ﹤0.01% 4095
2017
Q1 		$513K Buy
23,100
+15,100
+189% +$324K ﹤0.01% 5009
2016
Q4 		$151K Sell
8,000
-2,300
-22% -$56.3K ﹤0.01% 5945
2016
Q3 		$309K Sell
10,300
-400
-4% -$12.4K ﹤0.01% 5461
2016
Q2 		$411K Sell
10,700
-40,500
-79% -$1.68M ﹤0.01% 5041
2016
Q1 		$1.95M Sell
51,200
-58,900
-53% -$2.05M ﹤0.01% 3494
2015
Q4 		$4.84M Buy
110,100
+63,300
+135% +$3.14M ﹤0.01% 2857
2015
Q3 		$1.9M Buy
46,800
+21,500
+85% +$943K ﹤0.01% 3846
2015
Q2 		$1.35M Buy
25,300
+23,900
+1,707% +$1.27M ﹤0.01% 4251
2015
Q1 		$85K Buy
+1,400
New +$67.9K ﹤0.01% 6501

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Goldman Sachs's JUNO Position: Q1 2018 in Review

Goldman Sachs sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 1,594,770 shares — an estimated $72.9M sold.

Goldman Sachs first reported a position in JUNO in Q1 2015 and held it in 12 quarters. The position peaked at $72.9M in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • Goldman Sachs reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Goldman Sachs sold 1,594,770 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $72.9M.
  • Goldman Sachs first reported a position in Juno Therapeutics, Inc. in Q1 2015 and held it in 12 quarters.
  • Goldman Sachs's Juno Therapeutics, Inc. position peaked at $72.9M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Goldman Sachs's 13F filing for Q1 2018, filed 15 May 2018.